Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: A home-based nightcap evaluation during drug administration and withdrawal

Journal of Clinical Psychiatry

Volumn 62, Issue 8, 2001, Pages 642-652

  Silvestri, R ^a   Pace Schott, E F ^a   Gersh, T ^a   Stickgold, R ^a   Salzman, C ^a   Hobson, J A ^a  

^a MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; FLUVOXAMINE MALEATE; IBUPROFEN; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AMBULATORY MONITORING; AROUSAL; ARTICLE; CLINICAL ARTICLE; DATA ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; ELECTROMYOGRAM; FEMALE; HUMAN; MALE; MULTIVARIATE ANALYSIS; NONREM SLEEP; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP PATTERN; SLOW BRAIN WAVE;

EID: 0034858139     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0812     Document Type: Article

References (32)

1. The effects of fluoxetine on the polysomnogram of depressed outpatients: A pilot study
2. Modulation of rapid eye movement sleep in humans by drags that modify monoaminergic and purinergic transmission
3. Depression, sleep, and antidepressants
4. Effect of pharmacologic treatments on the sleep of depressed patients
5. Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality
6. The effect of fluoxetine on sleep EEG in childhood depression: A preliminary report
7. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients
8. Effects of fluoxetine on the polysomnogram in outpatients with major depression
9. Fluoxetine and oculomotor activity during sleep in depressed patients
10. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder
11. Fluoxetine produces persistent rapid eye movements in non-REM sleep
12. Fluoxetine-induced sleep disturbance in depressed patients
13. Serotonin reuptake inhibitor withdrawal
14. Pharmacokinetics of the selective serotonin reuptake inhibitors
15. Nightcap: Laboratory and home-based evaluation of a portable sleep monitor
16. The Nightcap can distinguish patients with severe sleep disordered breathing (sdb) from patients with less severe sbd and controls
17. The pharmacology of antidepressants at the synapse: Focus on newer compounds
18. The pharmacologic profile of paroxetine: A new selective serotonin reuptake inhibitor
19. Drug effects on REM sleep and on endogenous depression
20. Neurotransmitter systems
21. The neuropsychology of REM sleep dreaming
22. Fluvoxamine versus desipramine: Polysomnographic effects
23. Effects of antidepressant treatment on sleep EEG in depression
24. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities
25. The oculomotor system
26. Comparison of nightcap and polysomnography in detection of sleep onset using a modified MSLT protocol
27. Nightcap assessment of home and laboratory sleep
28. Quantification of rapid eye movements with the Nightcap